|
1
|
Jemal A, Siegel R, Ward E, Murray T, Xu J
and Thun MJ: Cancer statistics, 2007. CA Cancer J Clin. 57:43–66.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Calais G, Alfonsi M, Bardet E, Sire C,
Germain T, Bergerot P, Rhein B, Tortochaux J, Oudinot P and
Bertrand P: Randomized trial of radiation therapy versus
concomitant chemotherapy and radiation therapy for advanced-stage
oropharynx carcinoma. J Natl Cancer Inst. 91:2081–2086. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bussink J, van der Kogel AJ and Kaanders
JH: Activation of the PI3-K/AKT pathway and implications for
radioresistance mechanisms in head and neck cancer. Lancet Oncol.
9:288–296. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhu L, Wu K, Ma S and Zhang S: HDAC
inhibitors: A new radiosensitizer for non-small-cell lung cancer.
Tumori. 101:257–262. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kim IA, Kim IH, Kim HJ, Chie EK and Kim
JS: HDAC inhibitor-mediated radiosensitization in human carcinoma
cells: A general phenomenon? J Radiat Res (Tokyo). 51:257–263.
2010. View Article : Google Scholar
|
|
6
|
Zhang Y and Jung M, Dritschilo A and Jung
M: Enhancement of radiation sensitivity of human squamous carcinoma
cells by histone deacetylase inhibitors. Radiat Res. 161:667–674.
2004. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang F, Zhang T, Teng ZH, Zhang R, Wang
JB and Mei QB: Sensitization to gamma-irradiation-induced cell
cycle arrest and apoptosis by the histone deacetylase inhibitor
trichostatin A in non-small cell lung cancer (NSCLC) cells. Cancer
Biol Ther. 8:823–831. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yu J, Mi J, Wang Y, Wang A and Tian X:
Regulation of radiosensitivity by HDAC inhibitor trichostatin A in
the human cervical carcinoma cell line Hela. Eur J Gynaecol Oncol.
33:285–290. 2012.PubMed/NCBI
|
|
9
|
He G, Wang Y, Pang X and Zhang B:
Inhibition of autophagy induced by TSA sensitizes colon cancer cell
to radiation. Tumour Biol. 35:1003–1011. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Karagiannis TC, Smith AJ and El'Osta A:
Radio- and chemo-sensitization of human erythroleukemic K562 cells
by the histone deacetylase inhibitor Trichostatin A. Hell J Nucl
Med. 7:184–191. 2004.PubMed/NCBI
|
|
11
|
Zhang Y, Carr T, Dimtchev A, Zaer N,
Dritschilo A and Jung M: Attenuated DNA damage repair by
trichostatin A through BRCA1 suppression. Radiat Res. 168:115–124.
2007. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kim IA, Shin JH, Kim IH, Kim JH, Kim JS,
Wu HG, Chie EK, Ha SW, Park CI and Kao GD: Histone deacetylase
inhibitor-mediated radiosensitization of human cancer cells: Class
differences and the potential influence of p53. Clin Cancer Res.
12:940–949. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Dong Q, Sharma S, Liu H, Chen L, Gu B, Sun
X and Wang G: HDAC inhibitors reverse acquired radio resistance of
KYSE-150R esophageal carcinoma cells by modulating Bmi-1
expression. Toxicol Lett. 224:121–129. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Qu JQ, Yi HM, Ye X, Li LN, Zhu JF, Xiao T,
Yuan L, Li JY, Wang YY, Feng J, et al: MiR-23a sensitizes
nasopharyngeal carcinoma to irradiation by targeting IL-8/Stat3
pathway. Oncotarget. 6:28341–28356. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Balça-Silva J, Neves S Sousa, Gonçalves
AC, Abrantes AM, Casalta-Lopes J, Botelho MF, Sarmento-Ribeiro AB
and Silva HC: Effect of miR-34b overexpression on the
radiosensitivity of non-small cell lung cancer cell lines.
Anticancer Res. 32:1603–1609. 2012.PubMed/NCBI
|
|
16
|
Yang W, Shen Y, Wei J and Liu F:
MicroRNA-153/Nrf-2/GPx1 pathway regulates radiosensitivity and
stemness of glioma stem cells via reactive oxygen species.
Oncotarget. 6:22006–22027. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Shi L, Zhang S, Wu H, Zhang L, Dai X, Hu
J, Xue J, Liu T, Liang Y and Wu G: MiR-200c increases the
radiosensitivity of non-small-cell lung cancer cell line A549 by
targeting VEGF-VEGFR2 pathway. PLoS One. 8:e783442013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhao L, Bode AM, Cao Y and Dong Z:
Regulatory mechanisms and clinical perspectives of miRNA in tumor
radiosensitivity. Carcinogenesis. 33:2220–2227. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Isozaki Y, Hoshino I, Nohata N, Kinoshita
T, Akutsu Y, Hanari N, Mori M, Yoneyama Y, Akanuma N, Takeshita N,
et al: Identification of novel molecular targets regulated by tumor
suppressive miR-375 induced by histone acetylation in esophageal
squamous cell carcinoma. Int J Oncol. 41:985–994. 2012.PubMed/NCBI
|
|
20
|
Yin LH, Zheng XQ, Li HY, Bi LX, Shi YF, Ye
AF, Wu JB and Gao SM: Epigenetic deregulated miR-375 contributes to
the constitutive activation of JAK2/STAT signaling in
myeloproliferative neoplasm. Leuk Res. 39:471–478. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jia L, Huang Y, Zheng Y, Lyu M, Zhang C,
Meng Z, Gan Y and Yu G: miR-375 inhibits cell growth and correlates
with clinical outcomes in tongue squamous cell carcinoma. Oncol
Rep. 33:2061–2071. 2015.PubMed/NCBI
|
|
22
|
Manning BD and Cantley LC: AKT/PKB
signaling: Navigating downstream. Cell. 129:1261–1274. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Dent P, Yacoub A, Contessa J, Caron R,
Amorino G, Valerie K, Hagan MP, Grant S and Schmidt-Ullrich R:
Stress and radiation-induced activation of multiple intracellular
signaling pathways. Radiat Res. 159:283–300. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Meng Z and Gan YH: Activating PTEN by
COX-2 inhibitors antagonizes radiation-induced AKT activation
contributing to radiosensitization. Biochem Biophys Res Commun.
460:198–204. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hu S, Zhang M, Sun F, Ren L, He X, Hua J
and Peng S: miR-375 controls porcine pancreatic stem cell fate by
targeting 3-phosphoinositide-dependent protein kinase-1 (Pdk1).
Cell Prolif. 49:395–406. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tsukamoto Y, Nakada C, Noguchi T, Tanigawa
M, Nguyen LT, Uchida T, Hijiya N, Matsuura K, Fujioka T, Seto M, et
al: MicroRNA-375 is downregulated in gastric carcinomas and
regulates cell survival by targeting PDK1 and 14-3-3zeta. Cancer
Res. 70:2339–2349. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhou J, Song S, He S, Zhu X, Zhang Y, Yi
B, Zhang B, Qin G and Li D: MicroRNA-375 targets PDK1 in pancreatic
carcinoma and suppresses cell growth through the Akt signaling
pathway. Int J Mol Med. 33:950–956. 2014.PubMed/NCBI
|
|
28
|
Jia LF, Wei SB, Gong K, Gan YH and Yu GY:
Prognostic implications of micoRNA miR-195 expression in human
tongue squamous cell carcinoma. PLoS One. 8:e566342013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Harris T, Jimenez L, Kawachi N, Fan JB,
Chen J, Belbin T, Ramnauth A, Loudig O, Keller CE, Smith R, et al:
Low-level expression of miR-375 correlates with poor outcome and
metastasis while altering the invasive properties of head and neck
squamous cell carcinomas. Am J Pathol. 180:917–928. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Nohata N, Hanazawa T, Kikkawa N, Mutallip
M, Sakurai D, Fujimura L, Kawakami K, Chiyomaru T, Yoshino H,
Enokida H, et al: Tumor suppressive microRNA-375 regulates oncogene
AEG-1/MTDH in head and neck squamous cell carcinoma (HNSCC). J Hum
Genet. 56:595–601. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Jamali Z, Asl Aminabadi N, Attaran R,
Pournagiazar F, Oskouei S Ghertasi and Ahmadpour F: MicroRNAs as
prognostic molecular signatures in human head and neck squamous
cell carcinoma: A systematic review and meta-analysis. Oral Oncol.
51:321–331. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Song L, Liu S, Zeng S, Zhang L and Li X:
miR-375 modulates radiosensitivity of HR-HPV-positive cervical
cancer cells by targeting UBE3A through the p53 pathway. Med Sci
Monit. 21:2210–2217. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Cortez MA, Valdecanas D, Niknam S, Peltier
HJ, Diao L, Giri U, Komaki R, Calin GA, Gomez DR, Chang JY, et al:
In vivo delivery of miR-34a sensitizes lung tumors to radiation
through RAD51 regulation. Mol Ther Nucleic Acids. 4:e2702015.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kraus AC, Ferber I, Bachmann SO, Specht H,
Wimmel A, Gross MW, Schlegel J, Suske G and Schuermann M: In vitro
chemo- and radio-resistance in small cell lung cancer correlates
with cell adhesion and constitutive activation of AKT and MAP
kinase pathways. Oncogene. 21:8683–8695. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Li X, Chen F, Zhu Q, Ding B, Zhong Q,
Huang K, Jiang X, Wang Z, Yin C, Zhu Y, et al: Gli-1/PI3K/AKT/NF-κB
pathway mediates resistance to radiation and is a target for
reversion of responses in refractory acute myeloid leukemia cells.
Oncotarget. 7:33004–33015. 2016.PubMed/NCBI
|
|
36
|
Luo XM, Xu B, Zhou ML, Bao YY, Zhou SH,
Fan J and Lu ZJ: Co-inhibition of GLUT-1 expression and the
PI3K/Akt signaling pathway to enhance the radiosensitivity of
laryngeal carcinoma xenografts in vivo. PLoS One. 10:e01433062015.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wang L, Song G, Liu M, Chen B, Chen Y,
Shen Y, Zhu J and Zhou X: MicroRNA-375 overexpression influences
P19 cell proliferation, apoptosis and differentiation through the
Notch signaling pathway. Int J Mol Med. 37:47–55. 2016.PubMed/NCBI
|
